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With the definition of goals in Nutrition Science, we are taking a brave step and a leap of faith 
with regard to predicting the scope and direction of nutrition science over the next 5 years. 
The content of this editorial has been discussed, refined, and evaluated with great care by 
the Frontiers in Nutrition editorial board. We feel the topics described represent the key 
opportunities, but also the biggest challenges in our field. We took a clean-slate, bottom-up 
approach to identify and address these topics and present them in eight categories. For each 
category, the authors listed take responsibility, and deliberately therefore this document is a 
collection of thoughts from active minds, rather than a complete integration or consensus.
At Frontiers in Nutrition, we are excited to develop and share a platform for this discus-
sion. Healthy Nutrition for all – an ambition too important to be handled by detached 
interest groups.
Johannes le Coutre, Field Chief Editor, Frontiers in Nutrition
Sustainable development Goals for Food and nutrition 
(Barbara Burlingame, Chor San H. Khoo, and Dietrich Knorr)
To deliver successfully, nutrition research needs a bold dose of innovation. Moving forward from 
the Millennium Development Goals to the post-2015 sustainable development goals (SDG), global 
nutrition appears to require an improved model. Under current practices, feeding the exploding 
world population necessitates to close a gap of nearly 70% between the amount of food available 
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today and the projected availability by 2050 (1). Today, glob-
ally, an estimated 805 million people are undernourished or 
food insecure (2), yet one out of four calories from food goes 
uneaten. Meanwhile, overweight and obesity affect approximately 
two billion people, including 42 million children under the age 
of 5. Human health notwithstanding environmental health is 
also at stake. Agriculture alone accounts for about 70% of our 
global water usage and 24% of our greenhouse gas emissions. As 
a result, our strategies to overcome issues of food sustainability, 
food waste, and food loss must be multifarious and include, at 
the very least: (i) Improving the global consumption of food. (ii) 
Increasing production efficiencies on existing agricultural land. 
(iii) Developing sustainable approaches that reduce the environ-
mental impact of food production, and in particular greenhouse 
gas emissions. Certainly, the impact of agriculture on climate, 
ecosystems, and water will have to be reduced, while at the same 
time, we will need to ensure that it supports inclusive economic 
and social development (1).
Systems science, the interdisciplinary field that explores the 
nature of complex systems, is perhaps the best research model we 
have for addressing the urgent needs of a precariously unhealthy 
planet. For better or for worse, nutrition imparts a quintessential 
challenge, straddling many sectors and disciplines.
In the past, at times, the agenda for mainstream nutrition 
has been pushing sectoral lines of reasoning by implementing 
policies that leave long-standing problems unresolved, while 
disrupting other sectors in the process. Of course, nutrition is 
not alone in this, but the history of unintended consequence is 
long and discouraging (3, 4).
Agriculture and health have been the mainstay sectors at the 
United Nations level, in government ministries, and in academic 
departments. Increasingly, nutrition is being recognized as an 
important pillar for the environmental sector, with biodiver-
sity for food and nutrition acknowledged by the Convention 
on Biological Diversity (5), and the Commission on Genetic 
Resources for Food and Agriculture accepting whole diets, food, 
and nutrients for human nutrition as ecosystem services (6).
For all their embracing of nutrition, these sectors often work 
at cross-purposes, providing many useful illustrations of policies 
and programs that undermine each other’s development efforts. 
We have policies and interventions in agriculture that contribute 
to diet-related chronic disease, environmental degradation, 
and food insecurity (4, 7); conversely, in the health sector we 
have policies and interventions that compromise agricultural 
development (8); and in the environmental sector that lead to 
micronutrient malnutrition (9). Agriculture in particular, while 
solving some of its own sector problems, has been associated with 
many of the environmental and human health crises we now face, 
which directly impact upon nutrition, including chemical con-
tamination of food supplies, loss of agrobiodiversity, and severe 
environmental degradation (10).
In spite of the clear need to develop innovation for the future, 
“systematic attempts to explore existing methods and to develop 
new technologies of more sustainable food production systems 
have so far been scarce” (11). Although this quote is from over 
30 years ago, it still quite accurately describes the current situation 
regarding activities related to sustainable diets and sustainable 
food systems. A sustainable development lens with a systems 
science approach offers not only a new analytical model for 
nutrition, but also an ethical and inclusive framework. Within 
this framework, nutrition encompasses more than its traditional 
domains and takes on issues of climate change (12), biodiversity 
and ecosystems (13), water use/waste (14), food losses and waste 
(15, 16), sustainable forests and seas (17), chemical contamina-
tion of food and water supplies (18), environmental regulatory 
issues and food law, risk and risk/benefit assessments (19), 
and monitoring adherence to and compliance with a range of 
relevant treaties and signed declarations/commitments (13).
With this mindset of sensitive, cross-sectoral resolve, tangible 
and specific solutions will envisage a holistic food chain integra-
tion taking into account a total life cycle assessment. Food and 
nutrition security must be an intrinsic component of any solution 
for food sustainability. Forthcoming strategies will also have to 
explore the potential and utilization of new raw materials.
Improvements of food safety, storage, packaging, and trans-
portation – including the use of sensor technologies – can reduce 
food losses and waste. Innovation will have to equally encompass 
the re-evaluation of existing food processing, storage, and home 
preparation operations employing existing modern toolboxes. 
Moreover, low energy, waste-free or waste-reduced processing, 
and preparation operations need to be implemented to a larger 
extent, including alternative energy sources. In the same context, 
water decontamination, recycling, and preservation tools need to 
be applied.
Unintended consequences must be considered with any 
sustainability program and global solutions are not necessarily 
applicable in local contexts. For example, reducing livestock 
production and consumption in one setting may benefit both 
human and environmental health, while in another setting it 
may reduce further already marginal intakes of high-quality 
protein and micronutrients and marginalize grazing lands that 
are self-renewing, sustainable repositories of biodiversity. Finally, 
young engineers and scientists need to be encouraged, trained, 
and involved to tackle the challenges of the future.
We have a planet in crisis on so many fronts. Regardless of 
how the SDGs evolve, this multi-sectoral vision of nutrition 
research and action has the potential to make meaningful, and 
sustainable, contributions.
identifying and Mitigating errors in 
nutritional Science
(David B. Allison, Andrew W. Brown, and Tapan Mehta)
“Science,” as Adam Smith famously said, “is the great anti-
dote to the poison of enthusiasm and superstition” (20). 
Complementarily, Stephen Hawking has called scientists, “the 
bearers of the torch of discovery in our quest for knowledge” 
(21). Thus, science can be seen as having two key complementary 
roles – dispelling false beliefs, and creating new knowledge. For 
science to fulfill this joint mission, its practice must be true to 
its principles and precepts, including objectivity, methodological 
rigor, transparency, and reproducibility. Yet, there are concerns 
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that departures from these precepts are too common (22–28). 
Some have speculated that deviations from good scientific prac-
tices have increased in recent years due to a number of social, 
institutional, and economic factors in science (25, 29). Others 
have speculated that the problem may be especially severe in the 
related domains of nutrition research and obesity research, per-
haps because of emotional, economic, and other factors involved 
in those topics or because the everyday familiarity with aspects 
of those topics is mistaken for expertise (23, 26–28). It is difficult 
to quantify whether the situation is better or worse today than in 
the past, or whether this is especially true in nutrition and obesity 
research compared to other fields. Nevertheless, it is clear that the 
problem exists.
TaBle 1 | Common errors noted in the published literaturea.
error example(s) of error
Errors involving or 
resulting from poor 
measurement
•  Self-reported energy intake (33, 118, 119)b (34)c 
(32)d
•  Self-reported weights (120)b (121, 122)d
Errors involving 
inappropriate choice of  
or incorrect study  
design
 •  Cluster randomized trials with no degrees of 
freedom (123)c
 •  Lack of control for non-specific factors, i.e., failure 
to isolate the independent variable of interest (124)c
 •  Non-random assignment in self-described 
RCTs (125)b
Errors involving 
replication
 •  Not validating prediction models in fresh samples 
(126)d
 •  Gratuitous replication (35)d
Errors in statistical 
analyses
 •  Inappropriate baseline testing in parallel groups 
RCTs (127)c (128)d
 •  Failure to appropriately manage missing data (129)c 
(130, 131)d
 •  Not accounting for clustering in cluster randomized 
trials (132, 133)b (134, 135)c (136)d
Errors involving 
insufficient transparency 
in choices made about 
how to analyze and 
present the data
 •  Changing endpoints in a study (137)b (138)d
 •  Excessive or unacknowledged multiple testing 
[called p-hacking (139)d, investigator degrees of 
freedom (140)d, or p-value fiddling (141)d, among 
other names] (142)c (143)b
Errors of misleadingly 
describing past  
literature
 •  Selectively citing only the part of a study that 
supports a hypothesis (35)d
 •  Perpetuating citations from previous research 
without confirming the original source (144)b
Errors that distort the 
scientific record by 
publishing studies as 
a function of study 
outcomes
 •  Publication bias (145)b (23, 146)d
Errors of interpretation  
or communication
 •  Inappropriate use of causal language (24, 35)d
 •  Exaggerating or mis-describing results (35)d
 •  Highlighting benefits of treatment when the effects 
were non-significant (i.e., spin) (147)d
•  Issuing misleading press-releases (148)d
Errors of logic and 
mathematics
 •  Unreasonable linear extrapolations (e.g., 3500 kcal 
rule) (149, 150)b
aErrors, examples, and references were identified in a manner neither systematic nor 
comprehensive.
bDenotes references correcting or commenting on specific errors.
cDenotes references in which the error in question occurred.
dDenotes references that provide tutorials on avoiding or overviews of the errors.
Several initiatives are going to be important in the coming 
years to improve nutrition as a science. First is classifying errors 
that exist in the nutrition literature. Just as Mendeleev’s Periodic 
Table of the Elements led to increased understanding of chemistry 
and Linnaeus’ taxonomy of life led to a framework for the study of 
biology, if we can develop a “pathology” or classification of these 
errors, we may be better able to quantify the situation, identify pat-
terns, develop an understanding of origins, and ultimately reduce 
the occurrence and severity of these errors. In our non-systematic 
study of these issues, we see a number of categories of common 
errors (Table 1). We refer to them as errors without making any 
inference that they are intentional or unintentional errors.
Second, there is a general movement in science for 
“Transparency and Openness Promotion,” formalized in “The 
TOP Guidelines” (30). The guidelines recognize eight standards: 
citation, data transparency, analytic methods (code) transpar-
ency, research materials transparency, design and analysis 
transparency, preregistration of studies, preregistration of 
analysis plans, and replication. These standards aim to improve 
the communication of science, allowing improved understanding 
and replicability of results. Because the TOP Guidelines are being 
adopted across fields of science, the field of nutrition will not have 
to act in isolation to improve its scientific practices. Instead, we 
can build on and work with the minds and resources coming from 
a spectrum of scientific inquiry. Indeed, Frontiers in Nutrition was 
one of the initial signatories.
Third, there is a need to develop sound methodology for 
evaluating nutrition and diet in free-living research participants. 
Issues are continually documented with self-report diet method-
ology (31–33), and yet dietary recommendations depend heavily 
on dietary recall data (34). Similarly, although existing nutrition-
related health hypotheses can be investigated using randomized 
controlled trials (pragmatic or explanatory), the field often relies 
on ordinary association tests using observational data to quantify 
evidence (35, 36) that policy-makers may then use to create 
policies or guidelines. The needs here are twofold: to develop 
and implement study designs that lie in the causality spectrum 
between ordinary association tests and randomized controlled 
trials (37, 38) and to develop objective, reliable data on dietary 
patterns and nutrient status (31–33).
We believe that by recognizing and acknowledging these 
problems, we also recognize and acknowledge that our field can 
do better. This will pave the way toward constructive efforts to 
reduce such problems and to ultimately improve the scientific 
foundations of nutrition science.
Building the Foundation: Procurement of 
relevant Measures and Big data analysis
(Martin Kussmann, Josep Bassaganya-Riera, Raquel 
Hontecillas, Tapan Mehta, and Chor San H. Khoo)
Diet is considered a key environmental factor for maintaining 
health and preventing disease. As such, we need to better under-
stand the interactions of nutrition and lifestyle with an indi-
vidual’s genetic makeup in order to delay or prevent metabolic 
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and cognitive decline. Nutrition science is therefore undergoing 
a paradigm shift to better leverage the potential of nutrigenom-
ics, a discipline that is already transforming the field (39). To 
achieve this, the field will need to transform its current approach 
to research and implementation actions, and to take advantage 
of emerging advances in other disciplines  –  research designs, 
methods, new technologies, big data analysis, and bioinformation 
sharing.
The conceptual basis of gene  –  environmental interactions 
require not only research and technology, but also the cross-
fertilization of disciplines: genomics will encompass other-omics, 
and nutrition research will need to take on a holistic or system 
biology approach rather than just nutrients, ingredients, or 
genes. Nutrition science now encompasses more than the classic 
reductionist and descriptive approaches to more quantitative and 
systems-level approaches (40). Translational research to maintain 
health and prevent or delay disease onset requires a transdis-
ciplinary approach that embraces the complexity of human 
individuality in a rapidly changing environment. Nutrigenomics 
fuels this research by investigating how genomic and epigenomic 
individuality predisposes dietary, health, and disease responses. 
It also influences how an individual’s genome expresses itself 
at different omic levels (proteomics, metabolomics, lipidom-
ics) in response to environmental factors, including nutrition. 
Molecular phenotyping of humans over time and across healthy 
and safe exposures and challenges have thus been proposed (41).
Both the ongoing prevalence of malnutrition and the 
increasing incidence of nutrition- and lifestyle-related chronic 
diseases require comprehensive characterization of the complex 
interactions between environment and genetic makeup. Systems 
thinking in human nutrition, environment, and health requires 
improvement and translational thinking in three areas:
 (a) In vitro and in vivo models: a systems approach to human 
health implies rethinking of in vitro and in vivo models with 
regard to their translatability into human phenotypes: natu-
ral human cell models and panels of rodent strains should 
complement cancer cell lines and single rodent strains.
 (b) Human intervention study designs: classical case/control 
designs of human clinical/nutritional intervention studies 
should be complemented by longitudinal crossover stud-
ies, in which every subject is one’s own case and control. 
Human clinical study subjects should not only be assessed at 
homeostasis, but also during a challenge to, and restoration 
of, homeostasis.
 (c) Tools for molecular phenotyping and capturing of human 
diet and lifestyle: nutrigenomic studies have typically 
been technology-driven rather than technology-rooted. 
Normative science methods and approaches need to be com-
plemented by more comprehensive systems biology-based 
investigations deploying a multitude of omic platforms in 
an integrated fashion (41). While comprehensive and 
quantitative omics are rapidly progressing in terms of data 
generation, quantitative capture and monitoring of diet and 
lifestyle have lagged behind. Non-invasive technologies are 
now providing more attractive and precise image- and web-
based or body-wearable consumer/research interfaces (42). 
The bottleneck in knowledge generation has moved from 
(omics and clinical) data acquisition to processing, visuali-
zation, and interpretation. Innovative tools and methods for 
statistical treatment and biological network analysis are now 
at the forefront of nutritional and biomedical sciences (43).
To achieve this transformation and advancement of nutritional 
science, it is critical to connect researchers from all disciplines 
conducting direct or indirect research in the areas, e.g., (gen)
omics, clinicals, dietetics, food science and technology, physiol-
ogy, epidemiology, bioengineering, analytics, biomathematics. 
A transdisciplinary approach needs to be considered – enabling 
a spectrum of communicating and sharing from fundamental 
laboratory research, patient- and consumer-relevant outputs 
from personalized dietary/nutritional counseling to monitoring/
diagnostics. Progress in advancing nutrigenomic interventions 
for consumers and patients can only be accelerated if nutrition 
research is broadened to include quantitative, holistic, and 
molecular sciences (44).
“Let the food be your medicine, and medicine be your food,” 
a statement attributed to Hippocrates, the father of Western 
Medicine, delineates the impact of nutrition in human health 
and disease. Indeed, several decades of research at the interface 
of nutrition and immunology demonstrate that infectious, 
immune-mediated and metabolic diseases are safely and effec-
tively preventable through dietary interventions. Nonetheless, 
there is a major disconnect between the description of nutrition-
based protection from disease and an insufficient mechanistic 
understanding at the systems-level of the complex network 
interactions by which nutrition mediates clinical protection. As 
a result, a comprehensive understanding of the mechanisms of 
action underlying the actions of nutritional interventions and the 
combinatorial effects of nutrients (i.e., synergistic, antagonistic, 
or additive) at the systems-level remains largely unknown. As 
about 70% of the immune system is located in the gastrointes-
tinal tract since the gut mucosa houses the largest repertoire 
of immune cells and commensal microbiota that symbiotically 
coexist to elicit protective immunity, studying nutritional 
immunology of the gut mucosa is incredibly important (45). 
Coupling host-nutrient-microbiota actions, enabled through 
computational modeling of the gastrointestinal tract (46–50) with 
systems immunology frameworks has the potential to predict 
combinatorial outcomes of nutrient-microbiota–immune system 
interactions and advance toward a comprehensive systems-level 
mechanistic understanding of how nutrition and foods prevent 
disease. Computational models of nutritional immunology that 
funnel omics and cellular data judiciously, coupled with systems 
biology models of the underlying disease/organ, will bridge the 
connection between traditional methods of nutritional immu-
nology research and their effect on the whole organism, which 
will enhance mechanistic insights and translational value. Over 
163 nutrition themed systems biology markup language models 
(SBML) are already available in the Biomodels database (51). In 
summary, applying the iterative systems biology cycle of model 
building, calibration, refinement, and validation in nutritional 
immunology research has the potential to accelerate the discov-
ery of novel network biomarkers and systems-level mechanistic 
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understanding of the action of dietary components on immune 
responses.
There has been an explosion in data collection and aggrega-
tion, some of which can be used for public health purposes, 
including obesity and nutrition-related research. Consequently, 
ample opportunities emerge to utilize “big data” in the pursuit of 
interesting outcomes and effectiveness studies related to nutri-
tion and obesity using techniques such as quasi-experimental 
approaches. These approaches, when assumptions are satisfied, 
are intermediate between ordinary association tests and rand-
omized controlled trials (37) in terms of presenting evidence for 
causality. In this article, the term “big data,” which is often used 
subjectively, refers to very large amounts of data: structured and 
unstructured that may also increase over time rapidly (52). These 
types of data are collected by both the public and private sectors 
and increasingly require a distributed architecture to manage 
them efficiently. Big data analysis has generally referred to the 
confluence of statistical, machine learning and computational 
approaches to synthesize and analyze these large amounts of 
data. Administrative data, such as micro-level data aggregated by 
governments as well as private companies, can be used to evaluate 
the effectiveness of pharmacological and surgical interventions. 
In fact, private companies have started collecting unprecedented 
amounts of data with some companies specializing in data link-
ages. For example, companies such as Optum not only aggregate 
claims data from private insurance companies but are able to 
provide linked clinical data from the corresponding electronic 
health records (EHR). Data linkages are an extremely powerful 
tool since they allow researchers to answer questions that are 
otherwise not accessible using a single data source. For example, 
claims data do not provide information about the height and 
weight of an individual, but the linked clinical data do. Similarly, 
the increasing availability of EHR data and the initiatives to link 
these EHR data with genomic data can enable us to pursue a vari-
ety of studies, including pharmacogenetic and precision medicine 
studies. One of the challenges in accessing and leveraging “big 
data” is the resources, including the associated cost of purchas-
ing the data, especially from private companies. Collaborations 
between industry and academic researchers are essential to fully 
exploit the data and to overcome logistical challenges (53, 54).
So far, big data analysis has primarily focused on high-
dimensional prediction models. The data mining and statistical 
toolkit for such approaches includes, but is not limited to, 
techniques such as boosting, random forests, classification and 
regression trees, and lasso-like penalized regression models (53). 
While randomized control trials are considered gold standards, 
there are a variety of methods and designs that may allow us to 
generate evidence that may lie in the spectrum between purely 
association and definitively causal. Coupled with “big data” is an 
opportunity to estimate a degree of causality using techniques 
such as high-dimensional propensity score and differential 
comparison approaches to provide evidence that is indicative 
of causality (55, 56). There is also a potential to use instrument 
variable approaches, used commonly in health policy studies, 
by identifying appropriate instruments from “big data.” Recent 
attempts to develop methods that enable to provide a degree of 
causal evidence are very encouraging and can allow us to maxi-
mize the potential of “big data” (57, 58).
authenticity and Safety of Foods
(Michael Rychlik)
The authenticity of food is generally related to one or more of 
the following attributes: geographic origin, type of agricultural 
production, species and kind of raw materials, or certain process 
qualities such as sustainability or ecological foot print.
Regularly uncovered crises of food adulteration underline the 
sensitivity of consumers to this issue. Apart from meat, foods that 
are often adulterated are olive oil, fish, organic foods, spices, tea, 
cocoa, coffee, and nuts.
In recent years, there has been tremendous progress in high-
resolution methods to elucidate the molecular fingerprint of 
food. On the genetic scale, apart from classical polymerase chain 
reaction, new developments of isothermal amplifications or next 
generation sequencing will enable more accurate identification 
of species.
On the protein level, specific biomarker peptides can be used. 
For a fingerprint of metabolites, the new methods of non-targeted 
and targeted metabolomics already allow a specific authentica-
tion. In this field, the methods currently showing the best resolu-
tion are Fourier transform ion cyclotron mass spectrometry (FT/
ICR-MS) or nuclear magnetic resonance (NMR) spectroscopy 
(59). These new methodologies generate “big data,” from which 
the relevant information is only accessible when applying novel 
bioinformatics approaches.
Regarding food safety, microbiological decay and foodborne 
infections still play an important role. However, contaminants 
also endanger the safety of all links in the whole food chain. The 
recent discoveries of process contaminants encompass simple 
molecules, such as acrylamide, furan, benzene, styrene, as well 
as more complex compounds such as 3-monochloropropane-
1,2-diol (MCPD) esters. An end of new discoveries cannot be 
foreseen yet and we may assume that the sum of all these con-
taminants has a significant impact on life-style diseases such as 
cancer. Further new contaminants arise from packaging materials 
such as mineral oil saturated hydrocarbons (MOSH) or mineral 
oil aromatic hydrocarbons (MOAH), and pollutants from the 
environment such as the polyfluorinated alkyl substances (PFAS). 
Moreover, the historic toxin arsenic is more relevant than ever as 
rice and rice products are often contaminated and the mechanisms 
of arsenic carcinogenicity are still under controversial discussion.
Generally, risk assessment of food contaminants or residues 
is predominantly performed on single compounds. However, 
almost completely missing is an assessment of the combined 
effects of toxins, be it within one group of compounds or span-
ning various structural groups. The current concept for assessing 
combinatorial effects is that of cumulative assessment groups 
(CAGs), which, e.g., assess the cumulative potency corrected 
dose of acute reference doses (ARfD) for pesticides showing the 
same mode of toxic action (60). However, this approach is still 
preliminary and lacks comprehensive confirmation.
September 2015 | Volume 2 | Article 266
Allison et al. Goals in Nutrition Science
Frontiers in Nutrition | www.frontiersin.org
The Science Behind Food-related 
Behavior in humans
(Adrian Meule, Chor San H. Khoo, and Claus Vögele)
Numerous environmental, social, and individual factors influence 
human food choice and intake (61). In Western and Westernized 
societies, household expenditures and dietary energy availability 
decreased for unprocessed or minimally processed foods in the 
last decades while they increased for convenience foods and pro-
cessed products (62, 63). An environment where there is easy and 
frequent accessibility to food, and where cues signaling food are 
ubiquitous, requires constant self-monitoring and -regulation in 
order to prevent or manage weight gain (61). This, however, can be 
a highly effortful endeavor, leading many people to struggle with 
long-term weight maintenance. As evident from data from the 
last century, these self-regulatory efforts are made more difficult 
by increased consumption of energy-dense palatable foods and 
ingredients (e.g., sugar, fat, and salt) (64). As a result, some have 
argued that these foods might have an addictive potential and 
that a subset of individuals who have difficulties in controlling 
consumption of these foods may be addicted to them (65–68).
In the scientific literature, the association between food and 
addiction and the actual use of the term food addiction has a 
long history, dating back to the 1950s and even earlier times 
(69, 70). Not until recently, however, have researchers tried to 
more precisely define what is meant by food addiction and to 
systematically investigate its validity, as a consequence of which 
the number of publications, including the term food addiction, 
increased substantially over the past 5–6 years (65, 71). In humans, 
research on food addiction has been promoted by the Yale Food 
Addiction Scale (YFAS), a self-report questionnaire developed in 
2009, which measures symptoms of addiction-like eating based 
on the diagnostic criteria for substance dependence as outlined 
in the fourth version of the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV)(72). Since 2013, these diagnostic 
criteria have been revised in the fifth version of the DSM and a 
new version of the YFAS, which has been adapted accordingly, is 
currently under way (73).
Although research on food addiction is growing, it remains a 
controversial and debated topic with many researchers question-
ing the validity of the food addiction concept based on conceptual 
considerations or physiological mechanisms (74–78). To address 
these issues, more and better human studies are needed to resolve 
questions related to, for example, whether animal models of food 
addiction are transferable to human eating behavior (79, 80). These 
controversies, in particular, lead us to argue that food addiction 
research in humans is still in its infancy, that it would be premature 
to conclude that some foods are addictive, and that research efforts 
to clarify this will further increase in the years to come.
There are numerous avenues for future directions, which may 
include, but are not limited to: how do we define and harmonize 
definitions of food addiction? What are the implications of changes 
in the diagnostic criteria for substance dependence in the DSM-5 
for food addiction (73)? Are all addiction criteria (as described 
in the DSM-5) equally applicable to human eating behavior? If 
not, does this obliterate the concept of food addiction (81)? How 
can food addiction be measured in humans other than using the 
YFAS and which methodological improvements need to be made 
to better design human behavior studies, including randomized 
controlled trials (72)? How relevant is the concept of food addic-
tion for the treatment of obesity or binge eating and in public 
policy making? If it is relevant, how can it best be implemented 
(70, 82)? What are the disadvantages (if any) of the concept of 
food addiction (83–85)? How can animal models of addiction-like 
eating be improved to more specifically reflect relevant processes 
in humans (86)? Which foods are possibly addictive (87)? Can 
addiction-like eating actually be reduced to the addictive effects of 
substances or should the discussion about “food addiction” rather 
be replaced by a discussion on “eating addiction” (88)?
The Molecular and Physiological Science 
Underlying nutrition and Brain health
(Pierre Magistretti, Johannes le Coutre, and Suzanne 
L. Dickson)
Cognitive decline, dementia, Alzheimer’s disease, and other age-
related neurological diseases are on a rise in high income countries 
as well as in low and middle income countries (89). Achieving 
and maintaining brain health is a lifelong endeavor with identifi-
able targets that are specific for each period in a lifetime. Thus, 
targeting cognitive development in the early phases of life and 
preventing cognitive decline during aging are priorities for any 
preventive or interventional approach. While pharmacological 
approaches can only be envisioned for brief periods of time and, 
for the most part, have been unsuccessful, nutritional approaches 
are implementable for extended periods of time. Initiatives on 
brain health should incorporate a nutrition-based approach that 
can be implemented throughout the different phases of life.
In order to identify valid nutritional approaches for brain health, 
it is important to better understand the mechanisms that are at the 
basis of brain energy metabolism regulation. Key advances have 
been made in recent years in the identification of the molecular and 
cellular mechanisms that regulate the delivery of energy to active 
neurons. In particular, an active metabolic exchange has been char-
acterized between neurons and astrocytes with specific molecular 
steps that can become targets for nutritional interventions.
For the identification of the efficacy of such nutritional inter-
ventions, means for appropriate monitoring of markers need to be 
defined. This can be achieved by monitoring with brain imaging 
techniques, structural markers with morphometric approaches 
and myelination with MR as well as functional activation with 
fMRI, PET, EEG, and MRS, coupled with neuropsychological 
tests monitoring cognitive performance, motivation, and atten-
tion. The utility of these technologies goes beyond brain health 
and many of these approaches are being used to validate, in 
humans, the neuroscience of nutrition that, so far, has only been 
conducted in rodent models (90, 91).
There is no doubt that targeting the molecular steps of brain 
metabolism with nutritional interventions and monitoring their 
structural and functional outcomes in  vivo in humans, in par-
ticular regarding cognitive performance, represents a promising 
approach for developing nutritional interventions for achieving 
TaBle 2 | Variation in microbial ecology among individuals (102).
Each person’s microbiome is unique and no two individuals have the same 
microbiome (102). However, in spite of individual microbial differences, different 
individuals can still be considered healthy
Microbial communities across varying body regions may predict some 
characteristics such as breast fed history and educational level
Microbial communities from different body regions from an individual were 
predictive for others. For example, the oral community can be used to predict 
the gut community
Overall, low relative numbers of pathogens have been observed
Strong site specialization but considerable variation in diversity and abundance 
of each habitat’s signature microbes among subjects
Strong functional stability. This means that while the microbial compositions 
were widely different, the functionality is similar. This suggests flexibility to 
develop microbial communities that can provide similar performance
Wide variation in patterns of alpha and beta diversity (alpha-diversity within a 
site; beta diversity among subjects)
Correlations between ethnicity and microbiome composition across all body 
habitats
A positive correlation of vaginal pH to microbial diversity (higher pH having 
higher diversity)
An association of age with skin microbiome-associated metabolic pathways 
and oral microbiome composition
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brain health that can be maintained on the long term. Meaningful 
nutrient intake and nutritional intervention likely has an impact on 
the development of cognitive and behavioral performance meas-
ures, thereby determining our health span throughout life. Brain 
imaging studies on infants demonstrate how breast milk promotes 
healthy neural growth and early white matter  development (92).
Nutrients also engage brain pathways linked to metabolic 
control, appetite, and food-linked behaviors. There has been a 
general expectation that it must be possible to use food formula-
tion/composition to control how much and what we eat by altering 
the satiating and/or reward value of food combinations (93, 94). 
Currently, we lack a sufficient scientific evidence base that certain 
“unhealthy” foods fall short of “healthy” foods in their ability to 
induce satiation, limit hunger, or reduce hedonic over-eating. 
Moreover, it has not yet been demonstrated that any food or combi-
nation of foods has beneficial effects on appetite and energy intake 
of sufficient duration or magnitude to impact on body weight or 
metabolic health (95). This is a new and emerging field for which 
major advances are likely to progress through a better understand-
ing of how nutrients communicate with the appetite-regulatory 
brain networks. Nutrient-brain communication could be direct but 
likely engages intrinsic physiological control systems. For example, 
when we eat, sensing mechanisms in the gut signal information 
about the amount and content of the food to the brain by nervous 
and endocrine afferent signals. Indeed, gut-derived hormones such 
as ghrelin and glucagon-like peptide 1 communicate with hypo-
thalamic and brainstem areas linked to energy balance but also 
to brain areas processing the reward value of food and even brain 
areas linked to emotion and cognition (96, 97). Thus, while it seems 
clear that appetite-regulating hormones have a capacity to redirect 
behaviors important for governing how much and what we eat, 
the extent to which nutrients can control these behaviors through 
engaging intrinsic endocrine signals remains to be elucidated.
A related question is whether specific nutrients or food combi-
nations can act on the brain to reinforce their own intake, leading 
to addictive-like over-consumption. As reviewed recently (88) and 
as mentioned already in the previous section, it is very difficult 
to demonstrate in humans or rodents that foods act on the brain 
in a manner similar to addictive drugs, causing individuals to 
become addicted to them. It was suggested therefore that the term 
“eating addiction” rather than “food addiction” should be used to 
better describe addiction-like behavioral over-eating disorders. If 
it becomes possible to diagnose this patient group, e.g., through 
combining questionnaires about addictive-like behavior for food 
with brain imaging (98, 99), there will be a large public health 
impact on treatment and prevention strategies. Additionally, 
industrial stakeholders and politicians will need to find solutions 
to circumvent or treat eating addiction (88).
The Science of the human Microbiome
(Dietrich Knorr and Chor San H. Khoo)
The human body harbors over 8 million microbial genes, over 
10,000 species, and plays host to over a trillion microbes. Microbial 
cells outnumber human cells by a factor of 10 (100). As a result, 
there is considerable interest to better define and understand the 
microbial role in host physiology, health, and disease etiology. In 
the last decade, there has been a tremendous surge in microbiome 
research funded by programs such as the Human Microbiome 
Project (HMP) and the MetHIT Program. Advancing new and 
multiple technological approaches – whole genome sequencing, 
metagenomics, high-throughput-analysis, proteomics, transcrip-
tomics, cultivation, metabolomics, and bioinformatics – has led 
to new insights into microbial variety and abundance in 15–18 
body sites, including the oral cavity, skin, airway, gut, and vagina, 
from 242 healthy participants in the largest cohort study to date. 
Findings from this research were published in two seminal papers 
in 2012 by the Human Microbiome Consortium (100, 101). The 
HMP study has the largest collection of data on abundance and 
variety of the human microbiome, with 5,177 unique microbial 
taxonomic profiles from 16S ribosomal RNA genes, more than 
3.5 terabases of metagenomic sequence, and 800 reference strains 
isolated and sequenced (100). Noteworthy observations from the 
HMP study are outlined in Table 2 (102).
Translating learnings from emerging microbiome and health 
research presents exciting opportunities for future food and 
nutrition development. The use of microbes in food product 
development is not new. Fermented products are widespread and 
common in the market place. Food biotechnology has been in 
existence for more than 8,000 years (103). The potential health 
impact of gut microbiota has been postulated by Metchnikoff 
(104) and since then, numerous related research results have been 
provided (105–107). Probiotics are supplied in starter cultures 
and thus need to be preserved for transportation and use. As the 
highest possible cell density is required, losses that occur during 
processing, transportation, and storage, including in products, 
are detrimental. Consequently, approaches to increase and retain 
physiological fitness have been explored (108, 109).
Emerging capabilities to characterize microbial communities 
and their functions in the oral cavity present insights into the 
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role microbes may play in taste and olfaction, and present new 
opportunities to further personalize and refine food products 
to better suit individual taste and palatability preferences. Oral 
pre- and probiotics may be an opportunity for innovation.
These emerging advances in human microbiome structure, 
diversity, and function present exciting new opportunities for 
new food products, ingredients, or dietary approaches that can 
be used for supporting daily health, direct or adjunct intervention 
for risk reduction, or for new therapeutics for symptom reliefs 
(IBS). However, to advance these undertakings, several key ques-
tions need to be addressed. How easy is it to translate microbiome 
research to food and dietary applications? Limited well-designed 
studies have been performed that explore the impact of food 
and diet on microbial ecology and function. What biomarkers 
are available or need to be developed to understand how food 
and diet impact on the microbiome (gut, gut-brain, gut-kidney, 
etc.)? What microbial combination will be best suited for achiev-
ing specific outcomes? Of challenge is the ability to identify and 
separate the “good” from the “bad” microbes that can present 
food borne illness or exacerbate disease risks. Gene sequencing 
and whole genome sequencing technologies have been used to 
diagnose and trace food contamination, and are now also applied 
in medicine. How can current microbiome research be easily 
translated for food and product applications? How easy is it to 
transfer available technologies and tools already developed for 
use in food and nutrition applications?
In addition, there remains room for improvement when trans-
lating to innovative or tailor-made products. Needs and opportu-
nities include process generated structures, which impact on food 
properties (process–structure–function relationship) as outlined 
in the European Technology Platform Strategic Research Agenda 
(ETP SRA) (2007; 2012; 2014) for designing tailor-made foods 
for the targeted release of essential food constituents at points of 
need to support human microbiota growth and metabolic fitness. 
This needs to include the entire human digestion system encom-
passing the chewing apparatus, mouth microbiota, and enzymes. 
Moreover, food can contain viable microbial cultures as well as 
active enzymes. Understanding their role in and during diges-
tion as well as their impact on gut, mouth, and skin microbiota 
may lead to the development of new food design concepts with 
targeted nutritional benefits.
Finally, emerging technologies are being introduced to the 
food processing area, including high hydrostatic pressure, pulsed 
electric fields, and atmospheric plasma. Little is known about their 
impact and function with regard to the human microbiota. These 
technologies could open new avenues for process– function–
structure relationships as well as provide foods with metabolic 
properties not achieved via traditional processing (36).
nourishing the immune System and 
Preventing disease
(Johan Garssen, Willem van Eden, and Josep 
Bassaganya-Riera)
Whereas the disciplines of pharmaceutical and nutritional sci-
ences have evolved separately in the Western world, for Asia 
these two research areas have been connected for centuries. 
However, today, with the ever-growing burden of chronic diseases 
in modern societies, the high relevance of specialized nutrition in 
both prevention and therapeutic approaches receives increased 
attention and recognition. The gap between food and pharma 
is narrowing (110). One reason might be that, scientifically, the 
evidence for the so-called multi-target or polypharmacology 
approaches aimed at disease management is growing. Medical 
nutrition is beginning to be recognized as a unique and poten-
tially powerful area in Western societies at the interface between 
food and pharma.
Medical nutrition targets innovative nutritional therapies, 
offering healthcare professionals solutions to effectively manage 
disease-related malnutrition and specific disease states. Medical 
nutrition is and will be increasingly understood as a useful and 
sometimes even essential component in the management of 
patient health. Many medical conditions can be managed better 
when patients are receiving a specialized diet adapted to their 
unique circumstances. Sometimes, the constraints to appetite 
may be physical, as in the case of stroke patients who may find 
it difficult or impossible to swallow, or of young children with 
neurological disabilities. Sometimes, the problem may simply be 
insufficient intake, caused by the loss of appetite. It is well known 
that many chronic diseases are associated with malnutrition, a 
phenomenon that is not solely based on body mass index or body 
weight. Many obese patients suffer from specific malnutrition. 
Examples of disease areas that might be associated with specific 
malnutrition are cancer, stroke, and COPD. However, frail 
or elderly people are treated and fed with this type of medical 
nutrition as well. Medical nutrition might bring solutions and 
support to these cases across a broad range of care settings – in 
the hospital, in the care home, or in the community. It contains 
unique compositions of specific nutrients that would be impos-
sible or impractical to achieve through normal food intake alone. 
In most cases, it is administered via the gastrointestinal tract 
orally or with a feeding tube, utilizing the natural route for nutri-
ent digestion and absorption. These cases are underpinned by a 
unique scientific rationale, preclinical and clinical research, and 
health economic evaluation making it very similar to the tradi-
tional pharma approach. By making medical nutrition an integral 
part of care, patient outcomes are significantly improved. Lower 
healthcare costs by shortening hospital stays and keeping patients 
independent for longer are key outcomes for medical nutrition 
intervention. The food for special medical purposes (FSMP) is the 
regulatory directive involved with the quality/safety and efficacy 
of medical foods.
Another and unique medical area for which medical nutrition 
is aimed is disease-specific (the so-called disease targeted) medi-
cal nutrition. This type of medical nutrition is a unique, effective, 
therapeutic nutritional intervention for patients with, e.g., a 
clinical need to avoid certain nutrients due to specific diseases 
or conditions where normal food intake is harmful. Examples 
are inborn errors of metabolism such as phenylketonuria (PKU) 
or severe cow’s milk allergy and childhood epilepsy. Ketogenic 
therapy during refractory epilepsy can reduce seizures sig-
nificantly. Other examples for disease-specific medical nutrition 
are science-driven concepts containing different and uniquely 
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selected nutrients that can act in an orchestra leading to a delay 
in disease progression. Validated examples have been described 
for Alzheimer’s, HIV, diabetes, and cancer (111–114).
Disease-targeted medical nutrition can be aimed at conditions 
such as chronic inflammation. These inflammatory conditions are 
on the rise. This is caused by changes in life-style, food consumption 
patterns, and aging. Inflammation-associated conditions, such as 
atherosclerosis, type 1 and type 2 diabetes, obesity, Alzheimer’s 
disease, and many others, are a growing burden to health budg-
ets. Inflammatory conditions are thought to result from failing 
mechanisms of immunological tolerance. Of these mechanisms, 
deficient suppressive activities of a specialized subset of T cells, 
called regulatory T cells (Tregs), are being recognized as a major 
factor in the failure of immunological tolerance. A start has been 
made with the definition of antigen-specific Tregs with a broad 
anti-inflammatory effect, such as, for example, those that recog-
nize inflammation-associated stress-proteins (115). Herewith, the 
restoration of this regulation will be a widely sought goal, also for 
the field of nutrition. A telling example of what may be possible 
is the following. Wieten et al. have shown that the up-regulation 
of stress-proteins, such as heat shock protein 70 (HSP70), in the 
cells lining the gut, leads to the local induction of Tregs (116). 
Working with a model of chronic and relapsing arthritis, it was 
found that HSP70 was also induced in Peyer’s patches and the 
induced HSP70-specific Tregs were having a systemic effect seen 
to fully control arthritis. This up-regulation was achieved by 
the oral administration in mice of carvacrol, an essential oil of 
Oregano species. It showed that our diet may contain effective co-
inducers of stress-proteins and that these co-induced proteins can 
elicit anti-inflammatory activity in the immune system. Similar 
activities have now been described for other food components 
(117). Therefore, especially for the diets of the aging individual, 
substances with anti-inflammatory activities will be an attractive 
component. In the field of veterinary medicine and food animal 
production, restrictions are now being imposed on the use of anti-
biotics, certainly on the use of antibiotics as growth-enhancers. 
Also here, feed additives are searched with the purpose of control-
ling inflammation and thereby enhancing weight gain.
In combination with drugs, medical devices and lifestyle 
modification, medical nutrition, and immune system targeted 
nutraceuticals can play an essential role in health care and preci-
sion medicine. Expectedly, it will lead to lower costs of care: fewer 
complications, shorter hospital stays and reduced mortality, and 
the reduction of disease manifestations.
Over the coming years, Medical Nutrition and Nutraceuticals 
have the opportunity to be accepted as a bridge between food 
and traditional pharma approaches  –  not as isolated therapy 
but as part of integrated systems-wide health care. Additionally, 
pharma often is focusing on a monotherapeutic approach (one 
molecule one target) and medical nutrition will be recognized as 
the multi-target approach for disease management. Regulation 
and acceptance depends on national and international guide-
lines. Changes in regulation for medical nutrition are to be 
expected since medical nutrition is a relatively new therapeutic 
area that falls between different regulations and guidelines. For 
instance, in the USA, under section 5(b) of the Orphan Drug 
Act [21 U. S. C. 360ee (b)(3)], a medical food is formulated to 
be consumed or administered enterally under the supervision 
of a physician and which is intended for the specific dietary 
management of a disease or condition for which distinctive 
nutritional requirements, based on recognized scientific 
principles, are established by medical evaluation. Thus, from a 
regulatory perspective, medical foods are different than dietary 
supplements in that claims for medical foods can allude to dis-
ease management whereas dietary supplement claims cannot. 
Medical foods are exempted from the labeling requirements for 
health claims and nutrient content claims under the Nutrition 
Labeling and Education Act of 1990. In order to be a medical 
food, a product must meet the following criteria: to be a food for 
oral or tube feeding, the product must be labeled for the dietary 
management of a specific medical disorder, disease, or condi-
tion for which there are distinctive nutritional requirements, 
and the product must be intended to be used under medical 
supervision. Essentially, medical food comes into play when 
dietary management cannot be achieved by the modification of 
the normal diet alone. For instance, medical foods could be used 
to replete key metabolic components that might be depleted 
in diabetes or inflammation. Only translational research and 
randomized, placebo controlled double-blind clinical trials can 
validate these new concepts.
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